Biogen International GmbH v. Amneal Pharmaceuticals LLC
| SANDOZ INC., S&B PHARMA, INC., GRAVITI PHARMACEUTICALS PVT. LTD., MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD., MSN LABORATORIES PRIVATE LTD., GRAVITI PHARMACEUTICALS INC., SHILPA MEDICARE LIMITED, CIPLA USA INC., HETERO LABS LIMITED UNIT-III, CIPLA LIMITED, WINDLAS HEALTHCARE PVT. LTD., LUPIN ATLANTIS HOLDINGS SA, PHARMATHEN S.A., PRINSTON PHARMACEUTICAL INC., ALKEM LABORATORIES LTD., TORRENT PHARMA INC., SLAYBACK PHARMA LLC, TORRENT PHARMACEUTICALS LTD., ACCORD HEALTHCARE INC., AMNEAL PHARMACEUTICALS LLC, TWI PHARMACEUTICALS USA, INC., HETERO USA INC., TWI PHARMACEUTICALS INC., SLAYBACK PHARMA INDIA LLP, IMPAX LABORATORIES LLC, MSN PHARMACEUTICALS INC., ZYDUS PHARMACEUTICALS (USA) INC. and HETERO LABS LIMITED |
| BIOGEN INTERNATIONAL GMBH and BIOGEN MA INC. |
| 21-1078 |
| October 21, 2020 |
| U.S. Court of Appeals, Federal Circuit |
| Other |
Opinions
We have the following opinions for this case:
| Description |
|---|
| BIOGEN INTERNATIONAL GMBH v. AMNEAL PHARMACEUTICALS LLC |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 18, 2020. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 52
ORDER granting motion to extend time to file brief [ # 49 ]. The opening brief is due 02/04/2021. Service as of this date by the Clerk of Court. [743936] [NL] [Entered: 12/18/2020 03:15 PM]
|
| Filing 51 Notice from Appellees Hetero USA Inc., Hetero Labs Limited, Hetero Labs Limited Unit-III and Shilpa Medicare Limited Entry of Appearance for Saukshmya Trichi. Service: 12/17/2020 by email. [743488] [21-1078] [Saukshmya Trichi] [Entered: 12/17/2020 01:11 PM] |
| Filing 50 NOTICE OF NON-COMPLIANCE: The submissions of Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., and Shilpa Medicare Limited, Certificates of Interest [ # 46 ], [ # 48 ], are not in compliance with the rules of this court (see attached). Compliant document is due on 12/23/2020. Service as of this date by the Clerk of Court. [743057] [EKD] [Entered: 12/16/2020 08:45 AM] |
| Filing 49 MOTION of Appellants Biogen International GmbH and Biogen MA Inc. to extend the time to 02/04/2021 to file brief. Service: 12/14/2020 by email. [742508] [21-1078] [William Lee] [Entered: 12/14/2020 03:01 PM] |
| Filing 48 Certificate of Interest for Appellee Shilpa Medicare Limited. Service: 12/08/2020 by email. [741192] [21-1078] This document is non-compliant. See Doc No. [ # 50 ] [Todd Werner] [Entered: 12/08/2020 03:50 PM] |
| Filing 47 Entry of appearance for Todd S. Werner; Peter M. Kohlhepp as counsel for Appellee Shilpa Medicare Limited. Service: 12/08/2020 by email. [741188] [21-1078] [Todd Werner] [Entered: 12/08/2020 03:48 PM] |
| Filing 46 Certificate of Interest for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/08/2020 by email. [741182] [21-1078] This document is non-compliant. See Doc No. [ # 50 ] [Todd Werner] [Entered: 12/08/2020 03:43 PM] |
| Filing 45 Entry of appearance for Todd S. Werner; Peter M. Kohlhepp as counsel for Appellees Hetero Labs Limited, Hetero Labs Limited Unit-III and Hetero USA Inc.. Service: 12/08/2020 by email. [741178] [21-1078] [Todd Werner] [Entered: 12/08/2020 03:40 PM] |
| Filing 44 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 41 ], ERROR: The document contains a non-compliant signature. CORRECTION: For future filings, please use an electronic signature consisting of the printed name of the individual preceded by the mark /s/ entered on the signature line. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [740443] [EKD] [Entered: 12/04/2020 04:15 PM] |
| Filing 43 Docketing Statement for the Appellee Pharmathen S.A.. Service: 12/04/2020 by email. [740306] [21-1078] [H. Sabharwal] [Entered: 12/04/2020 11:53 AM] |
| Filing 42 Docketing Statement for the Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 12/03/2020 by email. [740187] [21-1078] [Jonathan Turpin] [Entered: 12/03/2020 09:12 PM] |
| Filing 41 Docketing Statement for the Appellees MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Sandoz Inc. and Prinston Pharmaceutical Inc.. Service: 12/03/2020 by email. [740001] [21-1078] [Maureen Rurka] [Entered: 12/03/2020 01:40 PM] |
| Filing 40 Notice to Appellees Accord Healthcare Inc., Graviti Pharmaceuticals Inc., Graviti Pharmaceuticals Pvt. Ltd., Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc., Impax Laboratories LLC, Macleods Pharma USA, Inc., Macleods Pharmaceuticals Ltd., Shilpa Medicare Limited, Slayback Pharma India LLP, Slayback Pharma LLC, TWi Pharmaceuticals Inc., Torrent Pharma Inc., Torrent Pharmaceuticals Ltd., Twi Pharmaceuticals USA, Inc., and Windlas Healthcare Pvt. Ltd.: The record of this case indicates that no Entry of Appearance under FCR 47.3(b) has been filed. The record of this case indicates that no Certificate of Interest under FCR 47.4 has been filed. The record of this case indicates that no Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [739757] [EKD] [Entered: 12/02/2020 04:31 PM] |
| Filing 39 Notice to Appellees MSN Laboratories Private Ltd., MSN Pharmaceuticals Inc., Pharmathen S.A., Prinston Pharmaceutical Inc., Sandoz Inc., and Zydus Pharmaceuticals (USA) Inc.: The record of this case indicates that no Docketing Statement under FCR 33.1(a) has been filed. Failure to file required documents may result in adverse action. See FCR 25(h). Service as of this date by the Clerk of Court. [739747] [EKD] [Entered: 12/02/2020 04:24 PM] |
| Filing 38 Corrected Certificate of Interest for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/24/2020 by email. [738061] [21-1078] [George Barry] [Entered: 11/24/2020 01:48 PM] |
| Filing 37 NOTICE OF NON-COMPLIANCE: The submission of Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc., Certificate of Interest [ # 34 ], is not in compliance with the rules of this court (see attached). Compliant document is due on 11/30/2020. Service as of this date by the Clerk of Court. [736979] [EKD] [Entered: 11/19/2020 01:53 PM] |
| Filing 36 Entry of appearance for Timothy H. Kratz; George J. Barry III as counsel for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/18/2020 by email. [736709] [21-1078] [George Barry] [Entered: 11/18/2020 03:05 PM] |
| Filing 35 Docketing Statement for the Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc.. Service: 11/18/2020 by email. [736706] [21-1078] [George Barry] [Entered: 11/18/2020 03:03 PM] |
| Filing 34 Certificate of Interest for Appellees Alkem Laboratories Ltd. and S&B Pharma, Inc. Service: 11/18/2020 by email. [736705] [21-1078] This document is non-compliant. See Doc No. [ # 37 ] [George Barry] [Entered: 11/18/2020 03:02 PM] |
| Filing 33 Corrected Docketing Statement for the Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734597] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:26 PM] |
| Filing 32 Corrected Certificate of Interest for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734596] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:24 PM] |
| Filing 31 Corrected Entry of appearance for William R. Zimmerman, principal counsel; Thomas P. Krzeminski, of cousel; Joseph M. Reisman, of counsel as counsel for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/09/2020 by email. [734595] [21-1078] [William Zimmerman] [Entered: 11/09/2020 07:21 PM] |
| Filing 30 Certificate of Interest for Appellees Sandoz Inc. and Prinston Pharmaceutical Inc.. Service: 11/09/2020 by email. [734515] [21-1078] [Maureen Rurka] [Entered: 11/09/2020 02:37 PM] |
| Filing 29 NOTICE OF NON-COMPLIANCE: The submissions of Appellees Cipla Limited and Cipla USA Inc. Entry of Appearance, and Appellees Prinston Pharmaceutical Inc. and Sandoz Inc. Certificates of Interest [ # 9 ], [ # 15 ], [ # 17 ], are not in compliance with the rules of this court (see attached). Compliant documents are due on 11/16/2020. Service as of this date by the Clerk of Court. [734206] [EKD] [Entered: 11/06/2020 12:11 PM] |
| Filing 28 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 12 ], Doc No. [ # 13 ], Doc No. [ # 14 ], Doc No. [ # 16 ], Doc No. [ # 21 ], Doc No. [ # 22 ], ERROR: The case number on the document is incomplete. CORRECTION: For future filings, please include all consolidated case numbers. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [734203] [EKD] [Entered: 11/06/2020 12:06 PM] |
| Filing 27 CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: Doc No. [ # 7 ], Doc No. [ # 8 ], Doc No. [ # 10 ], Doc No. [ # 11 ], Doc No. [ # 23 ], Doc No. [ # 24 ], Doc No. [ # 25 ], ERROR: The case number on the document is incomplete. The caption provided on the document does not follow the official caption provided by the Clerk. Please refrain from using "et al." CORRECTION: For future filings, please include all consolidated case numbers. For future filings, see Docket Entry #2 for the caption. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [734200] [EKD] [Entered: 11/06/2020 12:03 PM] |
| Filing 26 Entry of appearance for James B. Monroe; Paul W. Browning; J. Michael Jakes; Jason L. Romrell as counsel for Appellants Biogen MA Inc. and Biogen International GmbH. Service: 11/05/2020 by email. [734052] [21-1078] [James Monroe] [Entered: 11/05/2020 07:05 PM] |
| Filing 25 Certificate of Interest for Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733853] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:36 AM] |
| Filing 24 Docketing Statement for the Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733852] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:33 AM] |
| Filing 23 Entry of appearance for David J. Zimmer; Huiya Wu; Samuel E. Sherry as counsel for Appellee Amneal Pharmaceuticals LLC. Service: 11/05/2020 by email. [733851] [21-1078] [David Zimmer] [Entered: 11/05/2020 11:28 AM] |
| Filing 22 Certificate of Interest for Appellee Pharmathen S.A.. Service: 11/04/2020 by email. [733743] [21-1078] [Yun Wei] [Entered: 11/04/2020 11:32 PM] |
| Filing 21 Entry of appearance for H. Keeto Sabharwal; Yun Wei as counsel for Appellee Pharmathen S.A.. Service: 11/04/2020 by email. [733742] [21-1078] [Yun Wei] [Entered: 11/04/2020 11:30 PM] |
| Filing 20 Docketing Statement for the Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733734] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:29 PM] |
| Filing 19 Certificate of Interest for Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733733] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:27 PM] |
| Filing 18 Entry of appearance for Imron T. Aly as counsel for Appellee Lupin Atlantis Holdings SA. Service: 11/04/2020 by email. [733732] [21-1078] [Imron Aly] [Entered: 11/04/2020 06:26 PM] |
| Filing 17 Certificate of Interest for Appellee Sandoz Inc.. Service: 11/04/2020 by email. [733729] [21-1078] This document is non-compliant. See Doc No. [ # 29 ] [Maureen Rurka] [Entered: 11/04/2020 05:45 PM] |
| Filing 16 Entry of appearance for Maureen L. Rurka as counsel for Appellee Sandoz Inc.. Service: 11/04/2020 by email. [733728] [21-1078] [Maureen Rurka] [Entered: 11/04/2020 05:43 PM] |
| Filing 15 Certificate of Interest for Appellee Prinston Pharmaceutical Inc.. Service: 11/04/2020 by email. [733727] [21-1078] This document is non-compliant. See Doc No. [ # 29 ] [Maureen Rurka] [Entered: 11/04/2020 05:41 PM] |
| Filing 14 Entry of appearance for Maureen L. Rurka as counsel for Appellee Prinston Pharmaceutical Inc.. Service: 11/04/2020 by email. [733725] [21-1078] [Maureen Rurka] [Entered: 11/04/2020 05:39 PM] |
| Filing 13 Certificate of Interest for Appellees MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.. Service: 11/04/2020 by email. [733723] [21-1078] [John McNair] [Entered: 11/04/2020 05:35 PM] |
| Filing 12 Entry of appearance for George Lombardi; John R. McNair; Jovial Wong; Maureen L. Rurka as counsel for Appellees MSN Laboratories Private Ltd. and MSN Pharmaceuticals Inc.. Service: 11/04/2020 by email. [733722] [21-1078] [John McNair] [Entered: 11/04/2020 05:33 PM] |
| Filing 11 Certificate of Interest for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733717] [21-1078] [William Zimmerman] [Entered: 11/04/2020 05:28 PM] |
| Filing 10 Docketing Statement for the Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733716] [21-1078] [William Zimmerman] [Entered: 11/04/2020 05:26 PM] |
| Filing 9 Entry of appearance for William R. Zimmerman, principal counsel; Thomas P. Krzeminski, of counsel; Joseph M. Reisman, of counsel as counsel for Appellees Cipla Limited and Cipla USA Inc.. Service: 11/04/2020 by email. [733713] [21-1078] This document is non-compliant. See Doc No. [ # 29 ] [William Zimmerman] [Entered: 11/04/2020 05:24 PM] |
| Filing 8 Certificate of Interest for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/04/2020 by email. [733676] [21-1078] [Jonathan Turpin] [Entered: 11/04/2020 03:48 PM] |
| Filing 7 Entry of appearance for Michael J. Gaertner; Hugh S. Balsam; David B. Abramowitz; Timothy F. Peterson; Jonathan B. Turpin as counsel for Appellee Zydus Pharmaceuticals (USA) Inc.. Service: 11/04/2020 by email. [733670] [21-1078] [Jonathan Turpin] [Entered: 11/04/2020 03:32 PM] |
| Filing 6 Docketing Statement for the Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733640] [21-1078] [William Lee] [Entered: 11/04/2020 02:10 PM] |
| Filing 5 Certificate of Interest for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733638] [21-1078] [William Lee] [Entered: 11/04/2020 02:09 PM] |
| Filing 4 Entry of appearance for William F. Lee; William G. McElwain; Lisa J. Pirozzolo; Thomas G. Saunders; Madeleine C. Laupheimer; Annaleigh E. Curtis; Scott G. Greene as counsel for Appellants Biogen International GmbH and Biogen MA Inc.. Service: 11/04/2020 by email. [733635] [21-1078] [William Lee] [Entered: 11/04/2020 02:07 PM] |
| Filing 3 Note to File: The following cases are consolidated: 21-1078 Lead with 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, and 21-1098 Consolidated Member Cases. The parties must file all documents in the lead appeal only. [731161] [21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, 21-1098] [EKD] [Entered: 10/23/2020 04:09 PM] |
|
Filing 2
ORDER consolidating appeals 21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, and 21-1098. The opening brief for the consolidated appeals is due within 60 days from issuance of this order. Service as of this date by the Clerk of Court. [731158] [21-1078, 21-1084, 21-1086, 21-1087, 21-1088, 21-1090, 21-1091, 21-1092, 21-1093, 21-1094, 21-1095, 21-1096, 21-1097, 21-1098] [EKD] [Entered: 10/23/2020 04:03 PM]
|
| Filing 1 Appeal docketed. Received: 10/20/2020. [730610] Entry of Appearance is due on 11/04/2020. Certificate of Interest is due on 11/04/2020. Docketing Statement is due on 11/04/2020. Appellants' brief is due on 12/21/2020. [EKD] [Entered: 10/21/2020 02:50 PM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
